CureVac (CVAC) EBIAT (2019 - 2025)
Historic EBIAT for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $319.4 million.
- CureVac's EBIAT fell 1396.0% to $319.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.2 million, marking a year-over-year increase of 3161.21%. This contributed to the annual value of $173.3 million for FY2024, which is 16191.36% up from last year.
- As of Q3 2025, CureVac's EBIAT stood at $319.4 million, which was down 1396.0% from -$67.4 million recorded in Q2 2025.
- CureVac's EBIAT's 5-year high stood at $371.2 million during Q3 2024, with a 5-year trough of -$183.1 million in Q2 2021.
- For the 5-year period, CureVac's EBIAT averaged around -$34.3 million, with its median value being -$61.6 million (2023).
- Per our database at Business Quant, CureVac's EBIAT crashed by 39466081.03% in 2021 and then soared by 80054.67% in 2024.
- Quarter analysis of 5 years shows CureVac's EBIAT stood at -$2.2 million in 2021, then crashed by 5832.63% to -$131.4 million in 2022, then rose by 29.04% to -$93.2 million in 2023, then surged by 62.45% to -$35.0 million in 2024, then surged by 1012.41% to $319.4 million in 2025.
- Its EBIAT was $319.4 million in Q3 2025, compared to -$67.4 million in Q2 2025 and -$54.8 million in Q1 2025.